Business
ClearPoint Neuro Reports First Quarter 2026 Results
Record Revenue Achieved Including 25% Organic Growth in Devices and 43% Overall Growth SOLANA BEACH, CA / ACCESS Newswire / May 13, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company ...
About this update from Clearpoint Neuro Inc.
[{"type":"text","content":"Record Revenue Achieved Including 25% Organic Growth in Devices and 43% Overall Growth","length":86,"tagName":"p"},{"type":"text","content":"SOLANA BEACH, CA / ACCESS Newswire / May 13, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced financial results for its first quarter ended March 31, 2026.","length":302,"tagName":"p"},{"type":"text","content":"First Quarter 2026 Highlights","length":29,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Reported first quarter revenue of $12.1 million, including $2.3 million of IRRAflow revenue, representing 43% overall growth and 16% year-over-year total organic growth compared with the first quarter of 2025;","length":209,"tagName":"p"}]},{"val":[{"type":"text","content":"The activated installed base across all ClearPoint technology including IRRAflow systems now includes over 175 global centers;","length":126,"tagName":"p"}]},{"val":[{"type":"text","content":"Achievement of measurable revenue and cost synergies through the continuing integration of the IRRAflow product portfolio and team;","length":131,"tagName":"p"}]},{"val":[{"type":"text","content":"Continued clinical trial and regulatory progress across more than 60 active biopharma partners;","length":95,"tagName":"p"}]},{"val":[{"type":"text","content":"FDA clearance and successful completion of the first clinical procedure utilizing the Velocity Alpha MR High Speed Surgical Drill System;","length":137,"tagName":"p"}]},{"val":[{"type":"text","content":"Received Medical Device License (MDL) from Health Canada for the ClearPoint Neuro Navigation System, covering both MRI-guidance and iCT guidance workflows with first cases now scheduled;","length":186,"tagName":"p"}]},{"val":[{"type":"text","content":"Completion of the first commercial drug delivery case utilizing ClearPoint technology in the Asia-Pacific region;","length":113,"tagName":"p"}]},{"val":[{"type":"text","content":"Gross margin expanded to 64%; and","length":33,"tagName":"p"}]},{"val":[{"type":"text","content":"Reported cash and cash equivalents totaling $35.6 million as of March 31, 2026.","length":79,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":1109,"olType":false},{"type":"text","content...